Browse > Article
http://dx.doi.org/10.4110/in.2011.11.3.155

Ribosomal Protein L19 and L22 Modulate TLR3 Signaling  

Yang, Eun-Jeong (Department of Microbiology, Instititute for Immunology and Immunological Diseases, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine)
Seo, Jin-Won (Department of Microbiology, Instititute for Immunology and Immunological Diseases, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine)
Choi, In-Hong (Department of Microbiology, Instititute for Immunology and Immunological Diseases, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine)
Publication Information
IMMUNE NETWORK / v.11, no.3, 2011 , pp. 155-162 More about this Journal
Abstract
Background: Toll-like receptor 3 (TLR3) recognizes double-stranded RNA (dsRNA) and induces inflammation. In this study we attempted to ascertain if there are endogenous host molecules controlling the production of cytokines and chemokines. Two candidates, ribosomal protein L19 and L22, were analyzed to determine if they influence cytokine production followed by TLR3 activation. In this study we report that L19 acts upon production of IP-10 or IL-8 differently in glioblastoma cells. Methods: L19 or L22 was transfected into HEK293-TLR3, A549 or A172 cells. After treatment with several inhibitors of NF-${\kappa}B$, PI3K, p38 or ERK, production of IL-8 or IP-10 was measured by ELISA. siRNA was introduced to suppress expression of L19. After Vesicular stomatitis virus infection, viral multiplication was measured by western blot. Results: L19 increased ERK activation to produce IL-8. In A172 cells, in which TLR3 is expressed at endosomes, L19 inhibited interferon regulatory factor 3 (IRF3) activation and IP-10 production to facilitate viral multiplication, whereas L19 inhibited viral multiplication in A549 cells bearing TLR3 on their cell membrane. Conclusion: Our results suggest that L19 regulates TLR3 signaling, which is cell type specific and may be involved in pathogenesis of autoimmune diseases and chronic inflammatory diseases.
Keywords
RPL19; RPL22; TLR3;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hazeki K, Nigorikawa K, Hazeki O: Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull 30;1617- 1623, 2007   DOI   ScienceOn
2 Matsushima H, Yamada N, Matsue H, Shimada S: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 173;531-541, 2004   DOI
3 Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW: Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79;3350-3357, 2005   DOI   ScienceOn
4 Park C, Lee S, Cho IH, Lee HK, Kim D, Choi SY, Oh SB, Park K, Kim JS, Lee SJ: TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53;248-256, 2006   DOI   ScienceOn
5 Kutsch O, Oh J, Nath A, Benveniste EN: Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74;9214- 9221, 2000   DOI   ScienceOn
6 Guha M, Mackman N: The phosphatidylinositol 3-kinase- Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277;32124-32132, 2002   DOI
7 Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10; 1366-1373, 2004   DOI   ScienceOn
8 Diamond MS, Klein RS: West Nile virus: crossing the blood-brain barrier. Nat Med 10;1294-1295, 2004   DOI   ScienceOn
9 Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M: Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2;e53, 2006   DOI
10 Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M: Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 280;5571-5580, 2005
11 Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, Berlin AA, Lukacs NW: Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 176;1937-1942, 2006   DOI
12 Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW: Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 277;492-501, 2002   DOI
13 Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA: Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol 83; 1881-1891, 2009   DOI   ScienceOn
14 Bee A, Ke Y, Forootan S, Lin K, Beesley C, Forrest SE, Foster CS: Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clin Cancer Res 12(7 Pt 1);2061- 2065, 2006   DOI   ScienceOn
15 Deng L, Dai P, Parikh T, Cao H, Bhoj V, Sun Q, Chen Z, Merghoub T, Houghton A, Shuman S: Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double- stranded RNA binding protein, E3. J Virol 82;10735- 10746, 2008   DOI   ScienceOn
16 Leung DW, Ginder ND, Fulton DB, Nix J, Basler CF, Honzatko RB, Amarasinghe GK: Structure of the Ebola VP35 interferon inhibitory domain. Proc Natl Acad Sci U S A 106;411-416, 2009   DOI   ScienceOn
17 Maisnier-Patin S, Paulander W, Pennhag A, Andersson DI: Compensatory evolution reveals functional interactions between ribosomal proteins S12, L14 and L19. J Mol Biol 366;207-215, 2007   DOI   ScienceOn
18 Baril M, Racine ME, Penin F, Lamarre D: MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83; 1299-1311, 2009   DOI   ScienceOn
19 Fok V, Mitton-Fry RM, Grech A, Steitz JA: Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12;872-882, 2006   DOI   ScienceOn
20 Elia A, Vyas J, Laing KG, Clemens MJ: Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1. Eur J Biochem 271;1895-1905, 2004   DOI   ScienceOn
21 Finberg RW, Kurt-Jones EA: Viruses and Toll-like receptors. Microbes Infect 6;1356-1360, 2004   DOI   ScienceOn
22 Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173;3916-3924, 2004
23 Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol 42;859-867, 2005   DOI   ScienceOn
24 Schroder NW, Schumann RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5;156-164, 2005   DOI